DIPHENHYDRAMINE CITRATE AND IBUPROFEN

DIPHENHYDRAMINE CITRATE AND IBUPROFEN was reported 4509 times

DIPHENHYDRAMINE CITRATE AND IBUPROFEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMPAIRED ABILITY TO USE MACHINERY 1 0.0500
1 BLOOD ALCOHOL ABNORMAL 1 0.0303
2 DRUG EFFECT PROLONGED 16 0.0290
3 PRODUCT DIFFICULT TO SWALLOW 27 0.0266
4 FOREIGN BODY IN RESPIRATORY TRACT 23 0.0175
5 INCREASED VISCOSITY OF NASAL SECRETION 1 0.0167
6 ENEMA ADMINISTRATION 1 0.0152
7 PRODUCT SHAPE ISSUE 13 0.0138
8 INTERVENTIONAL PROCEDURE 1 0.0135
9 HANGOVER 40 0.0114
10 FOREIGN BODY 44 0.0110
11 CRANIAL NERVE INJURY 1 0.0103
12 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 283 0.0097
13 PHARYNGEAL INJURY 2 0.0095
14 PRODUCT COMMINGLING 10 0.0094
15 NAIL BED TENDERNESS 1 0.0088
16 DRUG EFFECT DELAYED 32 0.0071
17 LUDWIG ANGINA 1 0.0069
18 CAPSULE PHYSICAL ISSUE 1 0.0069
19 PRODUCT SIZE ISSUE 35 0.0065
20 POOR QUALITY DRUG ADMINISTERED 40 0.0062
21 HEPATOJUGULAR REFLUX 1 0.0060
22 DRUG EFFECT FASTER THAN EXPECTED 2 0.0060
23 DRUG SCREEN FALSE POSITIVE 15 0.0054
24 GLOMERULONEPHRITIS CHRONIC 1 0.0053
25 ADENOIDECTOMY 2 0.0052
26 EYELID SENSORY DISORDER 1 0.0051
27 ENERGY INCREASED 29 0.0049
28 WRONG DRUG ADMINISTERED 43 0.0048
29 GLOBAL AMNESIA 1 0.0047
30 RAPID EYE MOVEMENTS SLEEP ABNORMAL 2 0.0047
31 JAW CLICKING 1 0.0047
32 PRODUCT SELECTION ERROR 5 0.0046
33 FEELING OF RELAXATION 3 0.0044
34 ACUTE HIV INFECTION 1 0.0040
35 DRUG LABEL CONFUSION 1 0.0040
36 FALSE POSITIVE INVESTIGATION RESULT 4 0.0040
37 DRUG TOLERANCE INCREASED 3 0.0038
38 MARITAL PROBLEM 2 0.0037
39 CIRCADIAN RHYTHM SLEEP DISORDER 3 0.0036
40 OCULAR SURFACE DISEASE 1 0.0036
41 PRE-EXISTING CONDITION IMPROVED 22 0.0035
42 RESTLESS LEGS SYNDROME 59 0.0032
43 VIOLENCE-RELATED SYMPTOM 5 0.0032
44 MUSCLE TONE DISORDER 1 0.0032
45 DUPLICATE THERAPY ERROR 1 0.0031
46 HYPERVIGILANCE 3 0.0031
47 ANISOCYTOSIS 2 0.0030
48 SLEEP TALKING 5 0.0029
49 GENITAL SWELLING 2 0.0029
50 CONTRAINDICATED DRUG ADMINISTERED 2 0.0029
51 FOREIGN BODY IN THROAT 9 0.0029
52 DRUG EFFECT INCOMPLETE 99 0.0027
53 AMPHETAMINES POSITIVE 2 0.0027
54 MICTURITION FREQUENCY DECREASED 2 0.0027
55 FEELING JITTERY 49 0.0026
56 JOINT HYPEREXTENSION 1 0.0026
57 BLOOD ALCOHOL INCREASED 2 0.0026
58 PHYSICAL PRODUCT LABEL ISSUE 3 0.0025
59 POOR QUALITY SLEEP 54 0.0025
60 DRUG WITHDRAWAL HEADACHE 1 0.0024
61 MIDDLE INSOMNIA 45 0.0024
62 DEPERSONALISATION 2 0.0024
63 PRODUCT USED FOR UNKNOWN INDICATION 3 0.0024
64 GENE MUTATION IDENTIFICATION TEST POSITIVE 1 0.0024
65 PRODUCT LABEL ISSUE 16 0.0024
66 LAZINESS 4 0.0023
67 THERAPEUTIC PRODUCT EFFECT VARIABLE 9 0.0023
68 MOUTH BREATHING 1 0.0023
69 GINGIVAL BLISTER 1 0.0023
70 DRUG SCREEN POSITIVE 18 0.0023
71 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0022
72 PNEUMOPERITONEUM 4 0.0022
73 SCROTAL SWELLING 2 0.0021
74 SOMNOLENCE 424 0.0021
75 OPIATES POSITIVE 1 0.0021
76 RESTLESSNESS 75 0.0020
77 PRODUCT CLOSURE REMOVAL DIFFICULT 2 0.0020
78 KELOID SCAR 1 0.0019
79 URETEROLITHIASIS 2 0.0019
80 EXPULSION OF MEDICATION 1 0.0019
81 PSYCHOMOTOR HYPERACTIVITY 31 0.0019
82 PRODUCT NAME CONFUSION 2 0.0018
83 PRODUCT PHYSICAL ISSUE 37 0.0018
84 EXPIRED DRUG ADMINISTERED 9 0.0018
85 ENCEPHALOMALACIA 1 0.0018
86 DYSPRAXIA 1 0.0018
87 THERAPEUTIC PRODUCT EFFECT DELAYED 8 0.0018
88 CHOKING 34 0.0017
89 FLASHBACK 1 0.0017
90 HYPERTENSIVE ENCEPHALOPATHY 1 0.0017
91 AURICULAR SWELLING 1 0.0017
92 INTENTIONAL PRODUCT MISUSE 145 0.0017
93 PRODUCT USE COMPLAINT 26 0.0016
94 CHOKING SENSATION 9 0.0016
95 FEELING DRUNK 12 0.0016
96 GASTRIC NEOPLASM 1 0.0016
97 DRUG EFFECT DECREASED 85 0.0016
98 CHALAZION 1 0.0016
99 NIGHTMARE 53 0.0015
100 ABNORMAL SLEEP-RELATED EVENT 2 0.0015
101 TONGUE DRY 2 0.0015
102 IMPAIRED SELF-CARE 3 0.0014
103 FOREARM FRACTURE 1 0.0014
104 ECHOCARDIOGRAM ABNORMAL 2 0.0014
105 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
106 DRUG EFFECT LESS THAN EXPECTED 21 0.0014
107 ALCOHOL INTOLERANCE 1 0.0014
108 CERVICAL RADICULOPATHY 1 0.0014
109 PRODUCT USE IN UNAPPROVED INDICATION 346 0.0014
110 DRUG TOLERANCE 7 0.0014
111 PRODUCT PACKAGE ASSOCIATED INJURY 3 0.0013
112 BRAIN STEM SYNDROME 1 0.0013
113 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
114 ABNORMAL DREAMS 36 0.0013
115 EXPIRED PRODUCT ADMINISTERED 42 0.0013
116 HERPES ZOSTER DISSEMINATED 1 0.0012
117 WRONG DOSE 3 0.0012
118 CARTILAGE ATROPHY 1 0.0012
119 IIIRD NERVE PARALYSIS 1 0.0012
120 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
121 ACNE PUSTULAR 1 0.0012
122 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
123 TROPONIN I INCREASED 2 0.0012
124 PRODUCT TASTE ABNORMAL 16 0.0012
125 APTYALISM 1 0.0012
126 CORONARY ARTERY DISSECTION 1 0.0012
127 GINGIVAL ERYTHEMA 1 0.0012
128 OESOPHAGEAL OBSTRUCTION 1 0.0012
129 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
130 ROTATOR CUFF REPAIR 2 0.0011
131 NON-SMALL CELL LUNG CANCER METASTATIC 1 0.0011
132 CEREBELLAR ATROPHY 1 0.0011
133 TERMINAL INSOMNIA 2 0.0011
134 COELIAC DISEASE 11 0.0011
135 OPHTHALMIC HERPES ZOSTER 2 0.0011
136 LIP BLISTER 3 0.0011
137 LIGAMENT DISORDER 1 0.0011
138 NONSPECIFIC REACTION 6 0.0011
139 SOMNAMBULISM 7 0.0011
140 CEREBELLAR ATAXIA 1 0.0010
141 GASTRIC HAEMORRHAGE 12 0.0010
142 INFUSION SITE NODULE 1 0.0010
143 BLADDER CATHETERISATION 1 0.0010
144 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 7 0.0010
145 PRODUCT LABEL CONFUSION 6 0.0010
146 ALCOHOL INTERACTION 2 0.0010
147 ANIMAL SCRATCH 1 0.0010
148 OESOPHAGEAL PAIN 4 0.0010
149 FORMICATION 7 0.0010
150 THERAPEUTIC RESPONSE UNEXPECTED 43 0.0010
151 PHYSICAL ASSAULT 2 0.0010
152 CARPAL TUNNEL DECOMPRESSION 1 0.0009
153 SCREAMING 6 0.0009
154 INNER EAR DISORDER 1 0.0009
155 FEELING ABNORMAL 223 0.0009
156 CHEILITIS 5 0.0009
157 REACTION TO DRUG EXCIPIENTS 2 0.0009
158 CLAUSTROPHOBIA 1 0.0009
159 DYSPHAGIA 87 0.0009
160 INSOMNIA 244 0.0009
161 ACARODERMATITIS 1 0.0009
162 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
163 ASTHENOPIA 5 0.0009
164 PRODUCT FORMULATION ISSUE 6 0.0009
165 TONGUE BLISTERING 2 0.0009
166 DRUG INEFFECTIVE 1177 0.0009
167 DRUG EFFECT VARIABLE 1 0.0009
168 INITIAL INSOMNIA 9 0.0009
169 EYELID DISORDER 2 0.0009
170 REACTION TO EXCIPIENT 2 0.0009
171 APHTHOUS STOMATITIS 2 0.0009
172 NERVOUSNESS 45 0.0009
173 UTERINE DISORDER 2 0.0009
174 ALLODYNIA 1 0.0009
175 PRURITUS GENITAL 2 0.0008
176 HEAD DISCOMFORT 15 0.0008
177 PRODUCT PACKAGING ISSUE 8 0.0008
178 HYPERSOMNIA 24 0.0008
179 APPARENT DEATH 3 0.0008
180 PRODUCT PACKAGING CONFUSION 2 0.0008
181 SNORING 3 0.0008
182 ORAL DISCOMFORT 11 0.0008
183 PRODUCT COMPLAINT 20 0.0008
184 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
185 ADNEXA UTERI PAIN 1 0.0008
186 EUPHORIC MOOD 8 0.0008
187 EPIGASTRIC DISCOMFORT 3 0.0008
188 NON-HODGKIN'S LYMPHOMA 1 0.0008
189 PROSTATOMEGALY 3 0.0008
190 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
191 THROAT IRRITATION 34 0.0008
192 RETCHING 16 0.0007
193 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41 0.0007
194 BODY MASS INDEX INCREASED 1 0.0007
195 WRONG PRODUCT ADMINISTERED 5 0.0007
196 HEART RATE ABNORMAL 4 0.0007
197 JOINT INSTABILITY 1 0.0007
198 SLEEP TERROR 3 0.0007
199 APPENDIX DISORDER 1 0.0007
200 FEAR 19 0.0007
201 VITAMIN B12 DECREASED 2 0.0007
202 UPPER RESPIRATORY TRACT CONGESTION 2 0.0007
203 ESCHERICHIA SEPSIS 2 0.0007
204 SLUGGISHNESS 7 0.0007
205 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 48 0.0007
206 IMPETIGO 1 0.0007
207 ODYNOPHAGIA 4 0.0007
208 HYPOAESTHESIA ORAL 10 0.0007
209 MYELOFIBROSIS 2 0.0007
210 EAR DISORDER 3 0.0007
211 ACCIDENTAL DRUG INTAKE BY CHILD 1 0.0007
212 SEDATION 17 0.0006
213 ROSACEA 3 0.0006
214 THERAPEUTIC RESPONSE CHANGED 4 0.0006
215 CYSTITIS INTERSTITIAL 1 0.0006
216 ACUTE LEUKAEMIA 1 0.0006
217 INTENTIONAL PRODUCT USE ISSUE 54 0.0006
218 OEDEMA MOUTH 2 0.0006
219 MUSCLE TWITCHING 14 0.0006
220 ILLUSION 1 0.0006
221 ACCIDENTAL OVERDOSE 22 0.0006
222 FOOD AVERSION 1 0.0006
223 EXPOSURE TO SARS-COV-2 1 0.0006
224 BLADDER NEOPLASM 1 0.0006
225 REGURGITATION 2 0.0006
226 TACHYPHRENIA 2 0.0006
227 MALABSORPTION 3 0.0006
228 INTENTIONAL DRUG MISUSE 12 0.0006
229 BREAST DISCHARGE 1 0.0006
230 DRY MOUTH 46 0.0006
231 RENAL PAIN 6 0.0006
232 FEAR OF DISEASE 1 0.0006
233 PRODUCT CONTAMINATION 2 0.0006
234 APPLICATION SITE DISCOMFORT 1 0.0006
235 ESSENTIAL HYPERTENSION 1 0.0005
236 PARADOXICAL DRUG REACTION 2 0.0005
237 METAMORPHOPSIA 1 0.0005
238 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
239 GRANULOCYTE COUNT DECREASED 1 0.0005
240 LYMPH NODE PAIN 1 0.0005
241 AURA 1 0.0005
242 OVERDOSE 115 0.0005
243 NARCOLEPSY 1 0.0005
244 LIP DISORDER 1 0.0005
245 PHARYNGEAL OEDEMA 8 0.0005
246 MOTION SICKNESS 1 0.0005
247 SENSATION OF HEAVINESS 2 0.0005
248 ATROPHY 1 0.0005
249 EARLY SATIETY 1 0.0005
250 COLD SWEAT 9 0.0005
251 URINE ODOUR ABNORMAL 3 0.0005
252 SLEEP DISORDER 36 0.0005
253 SINUS HEADACHE 3 0.0005
254 GINGIVAL PAIN 4 0.0005
255 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
256 TINNITUS 23 0.0005
257 CARDIAC DISCOMFORT 1 0.0005
258 LIPIDS INCREASED 1 0.0005
259 GASTRIC DISORDER 17 0.0005
260 HOMICIDAL IDEATION 2 0.0005
261 DRY THROAT 5 0.0005
262 AGITATION 36 0.0005
263 POLYURIA 4 0.0005
264 NASAL DRYNESS 3 0.0005
265 MUSCLE FATIGUE 2 0.0005
266 TONGUE DISCOMFORT 2 0.0005
267 BODY HEIGHT DECREASED 5 0.0005
268 ALCOHOLISM 2 0.0005
269 DEREALISATION 1 0.0005
270 ABSCESS INTESTINAL 1 0.0005
271 HIATUS HERNIA 6 0.0005
272 LANGUAGE DISORDER 1 0.0005
273 FAECES DISCOLOURED 10 0.0005
274 TONGUE DISCOLOURATION 2 0.0005
275 HAEMORRHAGIC ANAEMIA 2 0.0005
276 BACTERIAL TEST POSITIVE 1 0.0004
277 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
278 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
279 FEAR OF DEATH 1 0.0004
280 IMPAIRED DRIVING ABILITY 5 0.0004
281 HAEMOGLOBIN INCREASED 2 0.0004
282 SCAB 5 0.0004
283 INTENTIONAL OVERDOSE 28 0.0004
284 NIGHT SWEATS 14 0.0004
285 FLANK PAIN 4 0.0004
286 EYE DISORDER 14 0.0004
287 SKIN ABRASION 2 0.0004
288 ABDOMINAL DISCOMFORT 70 0.0004
289 FAECAL INCONTINENCE 2 0.0004
290 SWELLING FACE 27 0.0004
291 BREATH ODOUR 1 0.0004
292 HORMONE LEVEL ABNORMAL 2 0.0004
293 BRONCHITIS CHRONIC 1 0.0004
294 INCORRECT DOSAGE ADMINISTERED 2 0.0004
295 EYE OEDEMA 1 0.0004
296 DENTAL OPERATION 1 0.0004
297 INFREQUENT BOWEL MOVEMENTS 1 0.0004
298 HEART RATE IRREGULAR 9 0.0004
299 LABYRINTHITIS 1 0.0004
300 EXTRA DOSE ADMINISTERED 16 0.0004
301 ENDODONTIC PROCEDURE 1 0.0004
302 PRODUCT COLOUR ISSUE 2 0.0004
303 STOMACH DISCOMFORT 2 0.0004
304 DELUSION 6 0.0004
305 PRODUCT ODOUR ABNORMAL 4 0.0004
306 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
307 ANORECTAL DISCOMFORT 2 0.0004
308 BLOOD POTASSIUM ABNORMAL 1 0.0004
309 BLISTER 21 0.0004
310 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
311 MUSCLE DISORDER 3 0.0004
312 PRESYNCOPE 9 0.0004
313 PRURITUS GENERALISED 8 0.0004
314 POST PROCEDURAL INFECTION 3 0.0004
315 CLUMSINESS 1 0.0004
316 CLONUS 1 0.0004
317 TOOTH FRACTURE 4 0.0004
318 PROSTATIC DISORDER 2 0.0004
319 PRODUCT USE ISSUE 68 0.0004
320 VERTIGO 22 0.0004
321 LIP SWELLING 12 0.0004
322 POLLAKIURIA 15 0.0004
323 DIZZINESS 179 0.0004
324 DRUG TOLERANCE DECREASED 1 0.0004
325 EJACULATION DISORDER 1 0.0004
326 OESOPHAGEAL STENOSIS 1 0.0004
327 HYPERTONIA 2 0.0003
328 LIP PAIN 1 0.0003
329 FIBULA FRACTURE 1 0.0003
330 MUSCLE STRAIN 3 0.0003
331 PARAESTHESIA ORAL 5 0.0003
332 PRODUCT ADMINISTRATION ERROR 7 0.0003
333 INCORRECT DOSE ADMINISTERED 79 0.0003
334 BILIARY COLIC 1 0.0003
335 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
336 GRIP STRENGTH DECREASED 3 0.0003
337 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
338 DYSGEUSIA 25 0.0003
339 THIRST 6 0.0003
340 CREPITATIONS 1 0.0003
341 TOOTHACHE 6 0.0003
342 LOSS OF EMPLOYMENT 1 0.0003
343 MASTICATION DISORDER 1 0.0003
344 DYSAESTHESIA 1 0.0003
345 ANGER 11 0.0003
346 DYSPEPSIA 32 0.0003
347 DIASTOLIC DYSFUNCTION 1 0.0003
348 PERSONALITY CHANGE 3 0.0003
349 THINKING ABNORMAL 6 0.0003
350 INFUSION SITE EXTRAVASATION 2 0.0003
351 DYSKINESIA 13 0.0003
352 LACERATION 3 0.0003
353 HALLUCINATION 24 0.0003
354 INFUSION SITE SWELLING 2 0.0003
355 PHOTOPSIA 2 0.0003
356 DRUG EFFECT INCREASED 1 0.0003
357 NON-CARDIAC CHEST PAIN 1 0.0003
358 ABDOMINAL PAIN UPPER 65 0.0003
359 GASTRIC ULCER 6 0.0003
360 BLADDER PAIN 1 0.0003
361 TREMOR 52 0.0003
362 ORAL PAIN 7 0.0003
363 DISCOMFORT 19 0.0003
364 PROCTALGIA 2 0.0003
365 MULTIPLE DRUG OVERDOSE INTENTIONAL 1 0.0003
366 LOOSE TOOTH 1 0.0003
367 PALPITATIONS 36 0.0003
368 POLYP 2 0.0003
369 VITREOUS FLOATERS 3 0.0003
370 PSYCHOTIC DISORDER 9 0.0003
371 INJECTION SITE INFECTION 1 0.0003
372 GASTRITIS 8 0.0003
373 LISTLESS 1 0.0003
374 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
375 DISORIENTATION 12 0.0003
376 HYPOAESTHESIA 45 0.0003
377 LYME DISEASE 1 0.0003
378 IRRITABILITY 18 0.0003
379 POST-TRAUMATIC STRESS DISORDER 2 0.0003
380 THROAT TIGHTNESS 8 0.0003
381 EYE SWELLING 11 0.0003
382 DIABETIC RETINOPATHY 1 0.0003
383 LIMB DISCOMFORT 9 0.0003
384 LEFT VENTRICULAR FAILURE 1 0.0003
385 PARANOIA 5 0.0003
386 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
387 MICTURITION DISORDER 1 0.0003
388 FEELING COLD 8 0.0003
389 HUNGER 4 0.0003
390 HYPERREFLEXIA 1 0.0003
391 RASH MACULAR 10 0.0003
392 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
393 PAPULE 2 0.0003
394 LOGORRHOEA 1 0.0003
395 DEVICE PLACEMENT ISSUE 1 0.0003
396 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
397 FRUSTRATION 1 0.0003
398 DECREASED ACTIVITY 3 0.0003
399 FACIAL BONES FRACTURE 1 0.0003
400 PANIC REACTION 2 0.0003
401 AMNESIA 18 0.0003
402 CAROTID ARTERY OCCLUSION 1 0.0003
403 MOUTH HAEMORRHAGE 2 0.0003
404 HEART RATE INCREASED 27 0.0003
405 PSYCHIATRIC SYMPTOM 2 0.0003
406 DIPLOPIA 7 0.0003
407 BONE DENSITY ABNORMAL 1 0.0003
408 LOSS OF CONTROL OF LEGS 1 0.0003
409 FACE INJURY 1 0.0003
410 TROPONIN INCREASED 2 0.0003
411 MICTURITION URGENCY 3 0.0003
412 COMMUNICATION DISORDER 1 0.0003
413 GINGIVAL DISORDER 1 0.0003
414 OESOPHAGEAL DISORDER 1 0.0003
415 OROPHARYNGEAL PAIN 24 0.0003
416 CONCUSSION 2 0.0003
417 NICOTINE DEPENDENCE 2 0.0003
418 FAECES HARD 1 0.0003
419 SWOLLEN TONGUE 8 0.0003
420 SPLENOMEGALY 3 0.0003
421 KIDNEY INFECTION 5 0.0003
422 BALANCE DISORDER 22 0.0003
423 HAEMATOCHEZIA 14 0.0003
424 MALAISE 111 0.0003
425 HALLUCINATION, AUDITORY 4 0.0003
426 ULCER 4 0.0003
427 UPPER LIMB FRACTURE 5 0.0003
428 CEREBRAL ATROPHY 1 0.0003
429 OBSTRUCTION 1 0.0003
430 BLOOD DISORDER 2 0.0002
431 SUICIDE ATTEMPT 15 0.0002
432 MUSCLE TIGHTNESS 4 0.0002
433 APPLICATION SITE DISCOLOURATION 1 0.0002
434 BACK DISORDER 4 0.0002
435 GOITRE 1 0.0002
436 DEMYELINATION 1 0.0002
437 APPLICATION SITE EXFOLIATION 1 0.0002
438 FATIGUE 189 0.0002
439 PHOTOSENSITIVITY REACTION 4 0.0002
440 GASTROINTESTINAL PERFORATION 1 0.0002
441 ACCIDENTAL EXPOSURE 1 0.0002
442 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
443 HALLUCINATION, VISUAL 5 0.0002
444 HEPATIC PAIN 1 0.0002
445 VITAMIN D DECREASED 2 0.0002
446 CONDITION AGGRAVATED 71 0.0002
447 MUSCULOSKELETAL DISCOMFORT 4 0.0002
448 HORDEOLUM 1 0.0002
449 HYSTERECTOMY 2 0.0002
450 SKIN SWELLING 2 0.0002
451 CHAPPED LIPS 1 0.0002
452 LOCAL SWELLING 4 0.0002
453 SPEECH DISORDER 12 0.0002
454 IMMOBILE 1 0.0002
455 ABNORMAL BEHAVIOUR 9 0.0002
456 GINGIVAL SWELLING 1 0.0002
457 BLOOD CREATINE INCREASED 1 0.0002
458 EYE HAEMORRHAGE 3 0.0002
459 IMPLANT SITE PAIN 1 0.0002
460 GLOSSODYNIA 5 0.0002
461 HAEMARTHROSIS 2 0.0002
462 SNEEZING 5 0.0002
463 CRYING 8 0.0002
464 OPTIC NEURITIS 2 0.0002
465 INJECTION SITE PAPULE 1 0.0002
466 PERIPHERAL COLDNESS 3 0.0002
467 MEMORY IMPAIRMENT 30 0.0002
468 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
469 MOVEMENT DISORDER 7 0.0002
470 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
471 DRUG INTOLERANCE 21 0.0002
472 DYSURIA 8 0.0002
473 EYE OPERATION 1 0.0002
474 NERVE COMPRESSION 2 0.0002
475 DIVERTICULITIS 6 0.0002
476 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
477 PROCEDURAL PAIN 6 0.0002
478 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
479 INTERCEPTED MEDICATION ERROR 1 0.0002
480 HYPERSENSITIVITY 40 0.0002
481 HAEMOPTYSIS 6 0.0002
482 URTICARIA 36 0.0002
483 SQUAMOUS CELL CARCINOMA 2 0.0002
484 FEELING HOT 13 0.0002
485 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 15 0.0002
486 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
487 BLOOD URINE PRESENT 4 0.0002
488 VIRAL INFECTION 7 0.0002
489 SKIN DISORDER 7 0.0002
490 MEDICATION RESIDUE PRESENT 1 0.0002
491 APHAGIA 1 0.0002
492 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
493 HYPOKINESIA 3 0.0002
494 FINGER DEFORMITY 1 0.0002
495 APATHY 3 0.0002
496 DYSSTASIA 6 0.0002
497 DRUG DEPENDENCE 33 0.0002
498 HEPATOMEGALY 2 0.0002
499 APPLICATION SITE BURN 1 0.0002
500 BREATH SOUNDS ABNORMAL 1 0.0002
501 FOOT OPERATION 1 0.0002
502 DRUG INTERACTION 32 0.0002
503 ABDOMINAL TENDERNESS 1 0.0002
504 ANEURYSM 1 0.0002
505 AGEUSIA 5 0.0002
506 BURNING SENSATION 14 0.0002
507 BRAIN INJURY 2 0.0002
508 PRODUCT QUALITY ISSUE 27 0.0002
509 ARTHROPATHY 11 0.0002
510 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
511 HAEMATEMESIS 5 0.0002
512 DRUG LEVEL DECREASED 2 0.0002
513 BLOOD PRESSURE INCREASED 30 0.0002
514 NEPHROLITHIASIS 9 0.0002
515 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
516 INCREASED UPPER AIRWAY SECRETION 1 0.0002
517 CEREBRAL ISCHAEMIA 1 0.0002
518 FLATULENCE 11 0.0002
519 ANKLE FRACTURE 3 0.0002
520 TENDONITIS 3 0.0002
521 DEAFNESS 5 0.0002
522 WEIGHT FLUCTUATION 2 0.0002
523 MUSCLE SPASMS 35 0.0002
524 HEADACHE 119 0.0002
525 ANXIETY 54 0.0002
526 SCRATCH 2 0.0002
527 RASH ERYTHEMATOUS 9 0.0002
528 EATING DISORDER 4 0.0002
529 IMPAIRED WORK ABILITY 4 0.0002
530 FOOD POISONING 1 0.0002
531 DYSARTHRIA 7 0.0002
532 DISTURBANCE IN ATTENTION 10 0.0002
533 BLOOD POTASSIUM INCREASED 3 0.0002
534 MENSTRUATION DELAYED 2 0.0002
535 PARAESTHESIA 29 0.0002
536 BACK INJURY 2 0.0002
537 OESOPHAGITIS 2 0.0002
538 FAECALOMA 1 0.0002
539 MANIA 3 0.0002
540 DRUG LEVEL INCREASED 3 0.0002
541 DENTAL CARIES 2 0.0002
542 GASTRIC ULCER HAEMORRHAGE 1 0.0002
543 FOOT DEFORMITY 2 0.0002
544 NERVE INJURY 2 0.0002
545 GAIT INABILITY 6 0.0002
546 DEMENTIA 5 0.0002
547 EYE PRURITUS 6 0.0002
548 ANGIOPATHY 1 0.0002
549 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
550 GENERALISED ERYTHEMA 1 0.0002
551 CHOLECYSTECTOMY 2 0.0002
552 LETHARGY 10 0.0002
553 PAIN IN EXTREMITY 51 0.0002
554 HOT FLUSH 13 0.0002
555 GAIT DISTURBANCE 33 0.0002
556 METABOLIC DISORDER 1 0.0002
557 RENAL DISORDER 8 0.0002
558 HYPERCHLORHYDRIA 1 0.0002
559 CONSTIPATION 37 0.0002
560 ATAXIA 2 0.0002
561 ACCIDENT 2 0.0002
562 WRIST FRACTURE 2 0.0002
563 RASH PRURITIC 9 0.0002
564 LACRIMATION INCREASED 5 0.0002
565 INJECTION SITE VESICLES 1 0.0002
566 MENTAL IMPAIRMENT 4 0.0002
567 NOCTURIA 2 0.0002
568 PANIC ATTACK 6 0.0002
569 NEURALGIA 4 0.0002
570 OEDEMA PERIPHERAL 20 0.0002
571 LOSS OF CONSCIOUSNESS 21 0.0002
572 DRUG ADMINISTRATION ERROR 5 0.0002
573 ENCEPHALOPATHY 4 0.0002
574 MUSCLE SPASTICITY 2 0.0002
575 DRUG ABUSER 1 0.0002
576 EMOTIONAL DISORDER 5 0.0002
577 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
578 OLIGURIA 1 0.0002
579 VISION BLURRED 22 0.0002
580 PHOTOPHOBIA 3 0.0002
581 BLEPHAROSPASM 1 0.0002
582 FRACTURE 3 0.0002
583 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 32 0.0002
584 FLUSHING 16 0.0002
585 SLEEP APNOEA SYNDROME 3 0.0002
586 CYSTITIS 5 0.0002
587 PERIPHERAL SWELLING 24 0.0002
588 GENITAL HAEMORRHAGE 2 0.0002
589 CARDIAC FLUTTER 1 0.0002
590 CONFUSIONAL STATE 25 0.0002
591 INCOHERENT 1 0.0002
592 ORAL HERPES 3 0.0002
593 ABDOMINAL DISTENSION 16 0.0002
594 BRADYPHRENIA 1 0.0002
595 SINUS DISORDER 3 0.0002
596 DEPRESSED MOOD 8 0.0002
597 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
598 BLOOD PRESSURE ABNORMAL 3 0.0002
599 COGNITIVE DISORDER 7 0.0001
600 CHOLECYSTITIS CHRONIC 1 0.0001
601 VOMITING 70 0.0001
602 FULL BLOOD COUNT DECREASED 3 0.0001
603 SINUS CONGESTION 2 0.0001
604 FEEDING DISORDER 3 0.0001
605 TASTE DISORDER 3 0.0001
606 OCULAR HYPERAEMIA 7 0.0001
607 HYPERHIDROSIS 19 0.0001
608 EPISTAXIS 11 0.0001
609 IMPAIRED GASTRIC EMPTYING 2 0.0001
610 MOOD ALTERED 4 0.0001
611 EYE MOVEMENT DISORDER 1 0.0001
612 HAEMATURIA 5 0.0001
613 ERYTHEMA 30 0.0001
614 ECCHYMOSIS 1 0.0001
615 CORONARY ARTERY OCCLUSION 2 0.0001
616 INFLUENZA LIKE ILLNESS 12 0.0001
617 APPLICATION SITE RASH 2 0.0001
618 JOINT EFFUSION 1 0.0001
619 LYMPHOEDEMA 1 0.0001
620 ENCEPHALITIS 1 0.0001
621 COORDINATION ABNORMAL 2 0.0001
622 PRURITUS 55 0.0001
623 DEFAECATION URGENCY 1 0.0001
624 MOUTH ULCERATION 3 0.0001
625 DUODENAL ULCER 1 0.0001
626 OSTEOARTHRITIS 6 0.0001
627 HAND FRACTURE 1 0.0001
628 JOINT INJURY 3 0.0001
629 SUBDURAL HAEMATOMA 2 0.0001
630 NAUSEA 110 0.0001
631 DERMATITIS BULLOUS 1 0.0001
632 PRODUCT DISPENSING ERROR 3 0.0001
633 BACK PAIN 32 0.0001
634 VISUAL IMPAIRMENT 17 0.0001
635 INTENTIONAL UNDERDOSE 1 0.0001
636 MELAENA 3 0.0001
637 APPLICATION SITE PAIN 3 0.0001
638 NASAL CONGESTION 8 0.0001
639 BLINDNESS TRANSIENT 1 0.0001
640 URINARY INCONTINENCE 4 0.0001
641 STEVENS-JOHNSON SYNDROME 3 0.0001
642 SKIN HAEMORRHAGE 2 0.0001
643 ARTHROPOD BITE 1 0.0001
644 RASH PAPULAR 3 0.0001
645 RESPIRATORY DISORDER 4 0.0001
646 MUSCULOSKELETAL PAIN 7 0.0001
647 MUSCULAR WEAKNESS 15 0.0001
648 COUGH 37 0.0001
649 AORTIC ANEURYSM 1 0.0001
650 BOWEL MOVEMENT IRREGULARITY 1 0.0001
651 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
652 MULTIPLE ALLERGIES 1 0.0001
653 ARTHRITIS 10 0.0001
654 PRODUCT PRESCRIBING ERROR 3 0.0001
655 MEDICATION ERROR 7 0.0001
656 RESPIRATORY TRACT CONGESTION 2 0.0001
657 MIGRAINE 12 0.0001
658 MOOD SWINGS 4 0.0001
659 ATRIAL FLUTTER 1 0.0001
660 ASTHENIA 47 0.0001
661 SENSORY DISTURBANCE 2 0.0001
662 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
663 EYE PAIN 7 0.0001
664 LOCALISED INFECTION 3 0.0001
665 FRUSTRATION TOLERANCE DECREASED 1 0.0001
666 PAIN 76 0.0001
667 BLOOD GLUCOSE INCREASED 23 0.0001
668 HAIR DISORDER 1 0.0001
669 DIARRHOEA 78 0.0001
670 MENSTRUAL DISORDER 1 0.0001
671 ACUTE CORONARY SYNDROME 1 0.0001
672 FALL 40 0.0001
673 SUICIDAL IDEATION 11 0.0001
674 SYNCOPE 12 0.0001
675 AGGRESSION 6 0.0001
676 DYSPHONIA 7 0.0001
677 ROAD TRAFFIC ACCIDENT 5 0.0001
678 BONE PAIN 7 0.0001
679 CHILLS 14 0.0001
680 WITHDRAWAL SYNDROME 5 0.0001
681 UNEVALUABLE EVENT 9 0.0001
682 DRUG USE DISORDER 1 0.0001
683 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
684 CIRCULATORY COLLAPSE 2 0.0001
685 URINARY TRACT INFECTION 20 0.0001
686 CHEST DISCOMFORT 12 0.0001
687 RECTAL HAEMORRHAGE 5 0.0001
688 RASH GENERALISED 3 0.0001
689 STOMATITIS 7 0.0001
690 RESPIRATORY TRACT INFECTION 3 0.0001
691 APPLICATION SITE ERYTHEMA 3 0.0001
692 DEPRESSION 26 0.0001
693 BLOOD CALCIUM INCREASED 1 0.0001
694 HEART RATE DECREASED 4 0.0001
695 HYPERTENSION 24 0.0001
696 LUNG INFILTRATION 1 0.0001
697 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
698 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
699 CARDIOTOXICITY 1 0.0001
700 FACIAL PAIN 1 0.0001
701 WEIGHT INCREASED 25 0.0001
702 PAIN OF SKIN 3 0.0001
703 ANAL INCONTINENCE 1 0.0001
704 LIP DRY 1 0.0001
705 DEPENDENCE 6 0.0001
706 BRAIN NEOPLASM 1 0.0001
707 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
708 ABDOMINAL PAIN 25 0.0001
709 DEFORMITY 1 0.0001
710 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
711 ARTERIOSCLEROSIS 1 0.0001
712 INTESTINAL OBSTRUCTION 4 0.0001
713 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
714 COLITIS 4 0.0001
715 NEUROPATHY PERIPHERAL 10 0.0001
716 DISEASE RECURRENCE 5 0.0001
717 CONVULSION 6 0.0001
718 ANGINA PECTORIS 3 0.0001
719 INCREASED APPETITE 2 0.0001
720 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
721 PRESCRIBED OVERDOSE 2 0.0001
722 DIZZINESS POSTURAL 1 0.0001
723 EAR PAIN 2 0.0001
724 AUTOIMMUNE DISORDER 1 0.0001
725 CHEST PAIN 19 0.0001
726 DYSPNOEA 58 0.0001
727 LIGAMENT SPRAIN 1 0.0001
728 BLADDER DISORDER 1 0.0001
729 MYALGIA 17 0.0001
730 JOINT SWELLING 12 0.0001
731 EMPHYSEMA 1 0.0001
732 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
733 MOTOR DYSFUNCTION 1 0.0001
734 BODY TEMPERATURE INCREASED 2 0.0001
735 EAR DISCOMFORT 1 0.0001
736 CARDIAC DISORDER 9 0.0001
737 HEAD INJURY 3 0.0001
738 FULL BLOOD COUNT ABNORMAL 1 0.0001
739 HIP FRACTURE 3 0.0001
740 IRRITABLE BOWEL SYNDROME 2 0.0001
741 LIVER FUNCTION TEST INCREASED 2 0.0001
742 HYPOACUSIS 4 0.0001
743 RHINORRHOEA 6 0.0001
744 MUSCULOSKELETAL STIFFNESS 8 0.0001
745 DRUG WITHDRAWAL SYNDROME 8 0.0001
746 TOOTH DISORDER 2 0.0001
747 URINARY RETENTION 3 0.0001
748 WEIGHT DECREASED 25 0.0001
749 RASH 39 0.0001
750 NECK PAIN 5 0.0001
751 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
752 BLOOD CALCIUM DECREASED 1 0.0001
753 INJECTION SITE BRUISING 7 0.0001
754 DERMATITIS CONTACT 1 0.0001
755 HERPES ZOSTER 5 0.0001
756 SHOCK 2 0.0001
757 MADAROSIS 1 0.0001
758 WHEEZING 5 0.0001
759 CHOLECYSTITIS 1 0.0001
760 MYOCLONUS 1 0.0001
761 HYPERLIPIDAEMIA 1 0.0001
762 MUSCLE RIGIDITY 1 0.0001
763 BLOOD PRESSURE FLUCTUATION 2 0.0001
764 BLOOD GLUCOSE DECREASED 4 0.0001
765 DEHYDRATION 11 0.0001
766 BURSITIS 1 0.0001
767 ADRENAL INSUFFICIENCY 1 0.0001
768 FIBROMYALGIA 2 0.0001
769 CYTOPENIA 1 0.0001
770 NASOPHARYNGITIS 15 0.0001
771 INJECTION SITE EXTRAVASATION 1 0.0001
772 ABASIA 2 0.0001
773 GENERALISED OEDEMA 1 0.0001
774 ILEUS 1 0.0001
775 HAIR COLOUR CHANGES 1 0.0001
776 DRY EYE 4 0.0001
777 DYSPNOEA EXERTIONAL 3 0.0001
778 ARTHRALGIA 33 0.0001
779 ABDOMINAL PAIN LOWER 2 0.0001
780 FLUID RETENTION 4 0.0001
781 INTRAOCULAR PRESSURE INCREASED 1 0.0001
782 HYPOPHAGIA 2 0.0001
783 MYDRIASIS 1 0.0001
784 INFUSION SITE PAIN 1 0.0001
785 ANAPHYLACTIC SHOCK 2 0.0001
786 INFLAMMATION 4 0.0001
787 DECREASED APPETITE 18 0.0001
788 INJECTION SITE INDURATION 1 0.0001
789 NODULE 1 0.0001
790 INCORRECT PRODUCT STORAGE 1 0.0001
791 BEDRIDDEN 1 0.0001
792 ANKYLOSING SPONDYLITIS 1 0.0001
793 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
794 ADVERSE REACTION 1 0.0001
795 EAR INFECTION 2 0.0001
796 HAIR TEXTURE ABNORMAL 1 0.0001
797 MENSTRUATION IRREGULAR 2 0.0001
798 MALIGNANT MELANOMA 1 0.0001
799 BLINDNESS 3 0.0001
800 PALLOR 2 0.0001
801 GINGIVAL BLEEDING 1 0.0001
802 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
803 CONTUSION 7 0.0001
804 RESPIRATORY DISTRESS 2 0.0001
805 ATRIAL FIBRILLATION 7 0.0001
806 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
807 INFLUENZA 8 0.0001
808 APHONIA 1 0.0001
809 BLOOD TEST ABNORMAL 1 0.0001
810 BLINDNESS UNILATERAL 1 0.0001
811 LYMPHOPENIA 1 0.0001
812 MOBILITY DECREASED 5 0.0001
813 EYE IRRITATION 4 0.0001
814 PRODUCT SUBSTITUTION ISSUE 4 0.0001
815 ANOSMIA 1 0.0001
816 HYPERTHYROIDISM 1 0.0001
817 INJECTION SITE HAEMATOMA 1 0.0001
818 GASTROENTERITIS 1 0.0001
819 CARDIOMYOPATHY 1 0.0001
820 CATARACT 4 0.0001
821 HAEMORRHAGE 7 0.0001
822 HAEMORRHAGE INTRACRANIAL 1 0.0001
823 BLOOD POTASSIUM DECREASED 2 0.0001
824 ALOPECIA 13 0.0001
825 CORONARY ARTERY DISEASE 2 0.0001
826 DRUG DISPENSING ERROR 1 0.0001
827 INSURANCE ISSUE 1 0.0001
828 HIP ARTHROPLASTY 1 0.0001
829 MUSCULOSKELETAL CHEST PAIN 1 0.0001
830 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
831 LUNG INFECTION 1 0.0001
832 BLOOD CHOLESTEROL INCREASED 3 0.0001
833 SWELLING 6 0.0001
834 BASAL CELL CARCINOMA 1 0.0001
835 NERVOUS SYSTEM DISORDER 2 0.0001
836 PULMONARY EMBOLISM 6 0.0001
837 COMA 3 0.0001
838 ANAEMIA 12 0.0001
839 MULTIPLE SCLEROSIS 3 0.0001
840 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
841 INFECTION 9 0.0001
842 PRODUCT DOSE OMISSION 4 0.0001
843 LUNG DISORDER 3 0.0001
844 IMPAIRED HEALING 2 0.0001
845 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
846 VISUAL ACUITY REDUCED 2 0.0001
847 BLOOD PRESSURE DECREASED 4 0.0001
848 DRUG ABUSE 5 0.0001
849 TYPE 2 DIABETES MELLITUS 2 0.0001
850 CEREBROVASCULAR ACCIDENT 10 0.0001
851 SINUSITIS 6 0.0001
852 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
853 PRODUCT STORAGE ERROR 5 0.0001
854 METASTASES TO LIVER 1 0.0001
855 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
856 INJECTION SITE ERYTHEMA 7 0.0001
857 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
858 ISCHAEMIC STROKE 1 0.0001
859 GASTROINTESTINAL DISORDER 5 0.0001
860 GOUT 1 0.0001
861 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
862 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
863 GASTROENTERITIS VIRAL 1 0.0001
864 COMPLICATION OF DEVICE REMOVAL 1 0.0001
865 HYPERGLYCAEMIA 2 0.0001
866 UNDERDOSE 4 0.0001
867 INJECTION SITE MASS 2 0.0001
868 SEPSIS 6 0.0001
869 PSORIASIS 7 0.0001
870 BLOOD SODIUM DECREASED 1 0.0001
871 ACNE 4 0.0001
872 MUSCULOSKELETAL DISORDER 1 0.0001
873 SEIZURE 6 0.0001
874 GLAUCOMA 1 0.0001
875 ERUCTATION 1 0.0001
876 DYSTONIA 1 0.0001
877 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
878 HAEMORRHOIDS 1 0.0001
879 DISABILITY 1 0.0001
880 INJECTION SITE HAEMORRHAGE 4 0.0001
881 PLEURAL EFFUSION 3 0.0000
882 DERMATITIS 1 0.0000
883 KNEE ARTHROPLASTY 1 0.0000
884 OFF LABEL USE 41 0.0000
885 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
886 VAGINAL HAEMORRHAGE 2 0.0000
887 DEVICE DISLOCATION 2 0.0000
888 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
889 LIVER DISORDER 2 0.0000
890 TACHYCARDIA 4 0.0000
891 NEOPLASM MALIGNANT 3 0.0000
892 DEVICE ISSUE 4 0.0000
893 ADVERSE DRUG REACTION 4 0.0000
894 THERAPY NON-RESPONDER 2 0.0000
895 SKIN IRRITATION 2 0.0000
896 SKIN DISCOLOURATION 2 0.0000
897 INJURY 3 0.0000
898 THERAPY INTERRUPTED 3 0.0000
899 PRODUCTIVE COUGH 2 0.0000
900 DIABETIC KETOACIDOSIS 1 0.0000
901 LIVER INJURY 1 0.0000
902 BRONCHITIS 3 0.0000
903 LEUKOPENIA 2 0.0000
904 HYPOTENSION 8 0.0000
905 CELLULITIS 2 0.0000
906 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
907 GASTRIC CANCER 1 0.0000
908 INJECTION SITE PAIN 12 0.0000
909 THERAPY CESSATION 2 0.0000
910 ERECTILE DYSFUNCTION 1 0.0000
911 DRUG RESISTANCE 1 0.0000
912 ILLNESS 4 0.0000
913 HAEMATOMA 1 0.0000
914 EXPOSURE VIA SKIN CONTACT 1 0.0000
915 MUCOSAL INFLAMMATION 1 0.0000
916 PLATELET COUNT DECREASED 4 0.0000
917 JAUNDICE 1 0.0000
918 PNEUMONIA 12 0.0000
919 FREQUENT BOWEL MOVEMENTS 1 0.0000
920 OEDEMA 2 0.0000
921 LIMB INJURY 1 0.0000
922 TREATMENT NONCOMPLIANCE 2 0.0000
923 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
924 CARDIAC ARREST 3 0.0000
925 DRUG DOSE OMISSION 6 0.0000
926 PANCYTOPENIA 2 0.0000
927 RENAL IMPAIRMENT 3 0.0000
928 OXYGEN SATURATION DECREASED 2 0.0000
929 SKIN EXFOLIATION 3 0.0000
930 INTENTIONAL DOSE OMISSION 1 0.0000
931 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
932 MYOCARDIAL INFARCTION 6 0.0000
933 COVID-19 6 0.0000
934 LABORATORY TEST ABNORMAL 1 0.0000
935 HEPATIC FAILURE 1 0.0000
936 APHASIA 1 0.0000
937 EMOTIONAL DISTRESS 4 0.0000
938 EXPOSURE DURING PREGNANCY 2 0.0000
939 PYREXIA 11 0.0000
940 DEEP VEIN THROMBOSIS 2 0.0000
941 BLOOD CREATININE INCREASED 2 0.0000
942 CHOLELITHIASIS 1 0.0000
943 FUNGAL INFECTION 1 0.0000
944 HEPATIC ENZYME INCREASED 2 0.0000
945 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
946 INJECTION SITE REACTION 2 0.0000
947 DELIRIUM 1 0.0000
948 LYMPHADENOPATHY 1 0.0000
949 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
950 SKIN BURNING SENSATION 2 0.0000
951 NO ADVERSE EVENT 5 0.0000
952 THROMBOCYTOPENIA 3 0.0000
953 CHRONIC KIDNEY DISEASE 2 0.0000
954 DIABETES MELLITUS 2 0.0000
955 INJECTION SITE SWELLING 2 0.0000
956 ABORTION SPONTANEOUS 1 0.0000
957 THROMBOSIS 2 0.0000
958 NEUTROPHIL COUNT DECREASED 1 0.0000
959 TOXICITY TO VARIOUS AGENTS 4 0.0000
960 DEVICE LEAKAGE 1 0.0000
961 MENTAL DISORDER 1 0.0000
962 ANGIOEDEMA 1 0.0000
963 DRY SKIN 3 0.0000
964 ADVERSE EVENT 2 0.0000
965 HYPOKALAEMIA 1 0.0000
966 ARRHYTHMIA 1 0.0000
967 PRODUCT DOSE OMISSION ISSUE 6 0.0000
968 ACUTE KIDNEY INJURY 3 0.0000
969 HOSPITALISATION 3 0.0000
970 HAEMOGLOBIN DECREASED 2 0.0000
971 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
972 ECZEMA 1 0.0000
973 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
974 ANAPHYLACTIC REACTION 1 0.0000
975 ASTHMA 2 0.0000
976 RHEUMATOID ARTHRITIS 2 0.0000
977 DEATH 15 0.0000
978 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
979 ILL-DEFINED DISORDER 1 0.0000
980 INFUSION RELATED REACTION 1 0.0000
981 RENAL FAILURE 2 0.0000
982 NEUTROPENIA 2 0.0000
983 DEVICE MALFUNCTION 1 0.0000
984 CARDIAC FAILURE CONGESTIVE 1 0.0000
985 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
986 DISEASE PROGRESSION 1 0.0000